Literature DB >> 234266

Long-term beta blockade: possible protection from myocardial infarction.

K M Fox, M P Chopra, R W Portal, C P Aber.   

Abstract

The clinical behaviour of 90 patients on beta-blocking drugs for established coronary heart disease who were admitted to a coronary care unit with prolonged ischaemic myocardial pain was compared with that of 90 similar patients not on this therapy. Transmural myocardial infarction was confirmed in 30 of the patients on beta-blockers and in 62 controls. A diagnosis of myocardial necrosis without infarction was made in 20 patients on beta-blockers and in 14 controls. Coronary insufficiency was diagnosed in 40 patients on beta-blockers and in 14 controls. The incidence of simus bradycardia, hypotension, syncope, and radiological pulmonary oedema was similar in the two groups. Established beta-blockade, therefore, has not been shown to prejudice the outcome of patients with coronary heart disease admitted to hospital with prolonged ischaemic myocardial pain. On the contrary, it may protect some patients from the development of a myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234266      PMCID: PMC1671936          DOI: 10.1136/bmj.1.5950.117

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  8 in total

1.  THE RECOGNITION OF STRICTLY POSTERIOR MYOCARDIAL INFARCTION BY CONVENTIONAL SCALAR ELECTROCARDIOGRAPHY.

Authors:  J K PERLOFF
Journal:  Circulation       Date:  1964-11       Impact factor: 29.690

2.  Discrepancies between electrocardiographic and enzyme evidence of myocardial infarction.

Authors:  P Marrott; M P Chopra; R W Portal; C P Aber
Journal:  Br Heart J       Date:  1973-12

3.  Coronary arterial spasm: a clinical entity?

Authors:  R A Carleton; A D Johnson
Journal:  Mod Concepts Cardiovasc Dis       Date:  1974-05

4.  Propranolol in the therapy of angina pectoris.

Authors:  P M Gillam; B N Prichard
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

5.  Beta-adrenergic blocking agents for the treatment of angina pectoris.

Authors:  W C Elliott; J M Stone
Journal:  Prog Cardiovasc Dis       Date:  1969-07       Impact factor: 8.194

6.  Velocity of contraction as a determinant of myocardial oxygen consumption.

Authors:  E H Sonnenblick; J Ross; J W Covell; G A Kaiser; E Braunwald
Journal:  Am J Physiol       Date:  1965-11

7.  The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects.

Authors:  S J Fischl; M V Herman; R Gorlin
Journal:  N Engl J Med       Date:  1973-06-07       Impact factor: 91.245

8.  Practolol in treatment of angina pectoris. A double-blind trial.

Authors:  C F George; R E Nagle; B L Pentecost
Journal:  Br Med J       Date:  1970-05-16
  8 in total
  12 in total

Review 1.  Selective versus nonselective beta adrenoceptor antagonists in hypertension.

Authors:  L M Van Bortel; A J Ament
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

2.  Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1977

3.  The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart.

Authors:  W F Lubbe; T Podzuweit; P S Daries; L H Opie
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

Review 4.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 5.  Beta-adrenoceptor blocking drugs and acute myocardial infarction.

Authors:  B N Singh
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

Review 6.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

7.  Activity and duration of action of pindolol and alprenolol compared in healthy volunteers.

Authors:  W H Aellig
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

8.  The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.

Authors:  J D Fitzgerald
Journal:  Postgrad Med J       Date:  1976-12       Impact factor: 2.401

9.  The incidence of myocardial infarction.

Authors:  D M Lambert
Journal:  J R Coll Gen Pract       Date:  1976-09

10.  Low-dose propranolol for the protection of the left ventricle from ischaemic damage.

Authors:  A H Brown; B L Krause; G M Morritt
Journal:  Thorax       Date:  1981-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.